Evidence map›Paper›PMID 33047636›Full record

ArticleLeukemia & lymphoma2021

The association of health behaviors with quality of life in lymphoma survivors.

Priyanka A Pophali, Melissa C Larson, Allison C Rosenthal, Dennis Robinson, Thomas M Habermann, Gita Thanarajasingam, Timothy Call, Cristine Allmer, Umar Farooq, Matthew J Maurer and 3 more

Open access · greenAbstract read
In one paragraph

Article in Leukemia & lymphoma, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Quality of Life and Survivorship in Lymphoma.Current oncology reports · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Priyanka A PophaliDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-2410-9540
Melissa C LarsonDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Allison C RosenthalDivision of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, AZ, USA.
Dennis RobinsonDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Thomas M HabermannDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Gita ThanarajasingamDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-2144-5415
Timothy CallDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Cristine AllmerDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Umar FarooqDivision of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Iowa City, IA, USA.
Matthew J MaurerDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-1867-0526
Kathleen J YostDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
James R CerhanDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Carrie A ThompsonDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Florida · USMayo Clinic in Arizona · USUniversity of Iowa · USUniversity of Wisconsin Carbone Cancer Center · USWinnMed · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI LENTZ, STEVEN R · 2002 to 2021
$45.7M
ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)U01CA195568 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R, FLOWERS, CHRISTOPHER R · 2015 to 2025
$22.1M
Institutional Career Development CoreKL2TR002379 · NCATS · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2017 to 2026
$14.9M
NCATS NIH HHS KL2 TR002379NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA097274NCI NIH HHS U01 CA195568NCRR NIH HHS M01 RR000585
6 · The paper itself

Abstract

The impact of change in health behaviors (physical activity [PA], alcohol and smoking) on quality of life (QOL) in lymphoma survivors is not well understood. We evaluated the associations of health behaviors with QOL domains at diagnosis and at 3-year follow-up (FU3) in 2805 lymphoma survivors. We report clinically significant QOL score differences, defined as scores that exceeded a minimally important difference threshold and were statistically significant. Current smoking was associated with lower QOL at baseline (

Indexed as

LymphomaQuality of LifeExerciseHealth BehaviorHumansSurveys and QuestionnairesSurvivorslymphoid leukemiaLymphoma and Hodgkin diseaseprognostication

Identifiers

PMID33047636
PMCPMC8063513
OpenAlexW3092024031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.